 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
WGS IDs Markers of Response to Aromatase Inhibitors; New Trial Will Use Signatures to Guide Treatment
June 13, 2012
WGS IDs Markers of Response to Aromatase Inhibitors; New Trial Will Use Signatures to Guide Treatment
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Wash U Team Looks to Expand on Initial Success of Sequencing in Breast Cancer Clinical Trial
April 5, 2011 / Clinical Sequencing News - Sequencing, Though Not Always a Slam Dunk, Gains Traction in Genomic Medicine
March 13, 2013 / Clinical Sequencing News - Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012 / Clinical Sequencing News - Wash U Team Finds Genomic Profile May Predict Aromatase Inhibitor Response in Breast Cancer Patients
June 11, 2012 / GenomeWeb Daily News - WUSTL, ICR to Use $4M Komen Grant to Develop Breast Cancer Dx, Screen Treatments
June 4, 2012 / GenomeWeb Daily News